Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
CALGB 30601: A phase II study of dasatinib (D) in patients (pts) with previously treated malignant mesothelioma (MM) Proceeding/Conference:Journal of Clinical Oncology | 2010 |